Payment overview · 2025
General Payments
$987.33
8 reported records · 6 companies
Healthcare provider profile · identity verified
Patrick J Kerrigan, DO
Allopathic & Osteopathic Physicians|Family Medicine · WILKES BARRE, PA · NPI 1659471910
Verified facts
What the public records show
CMS Open Payments records show Patrick J Kerrigan, DO received $987.33 in general payments during 2025 across 8 reported records.
Medtronic, Inc. accounted for 29.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$291.23 | 29.5% | 2 | 2025 |
| Actelion Pharmaceuticals US, Inc. | Unresolved — no canonical attribution shown | $244.18 | 24.7% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $137.31 | 13.9% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $124.93 | 12.7% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $102.06 | 10.3% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $87.62 | 8.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $987.33 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OPSUMIT Normalized: opsumit |
Drug | Actelion Pharmaceuticals US, Inc. | $244.18 | 2 | 2025 |
Source payment records
|
|||||
| UPTRAVI Normalized: uptravi |
Drug | Actelion Pharmaceuticals US, Inc. | $244.18 | 2 | 2025 |
Source payment records
|
|||||
| SYMPLICITY G3 Normalized: symplicity g3 |
Device | Medtronic, Inc. | $171.23 | 1 | 2025 |
Source payment records
|
|||||
| General - Pain Management Normalized: general pain management |
Device | Boston Scientific Corporation | $137.31 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $124.93 | 1 | 2025 |
Source payment records
|
|||||
| CATALYFT PL EXPANDABLE INTERBODY SYSTEM Normalized: catalyft pl expandable interbody system |
Device | Medtronic, Inc. | $120.00 | 1 | 2025 |
Source payment records
|
|||||
| Sunosi Normalized: sunosi |
Drug | Axsome Therapeutics, Inc. | $102.06 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $87.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 616 | 144 |
| Levothyroxine Sodium | Levothyroxine Sodium | 566 | 124 |
| Lisinopril | Lisinopril | 480 | 100 |
| Alprazolam | Alprazolam | 409 | 97 |
| Pantoprazole Sodium | Pantoprazole Sodium | 390 | 90 |
| Furosemide | Furosemide | 378 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 373 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 320 | 70 |
| Simvastatin | Simvastatin | 300 | 69 |
| Famotidine | Famotidine | 275 | 74 |
| Gabapentin | Gabapentin | 275 | 52 |
| Meloxicam | Meloxicam | 244 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 231 | 52 |
| Losartan Potassium | Losartan Potassium | 213 | 45 |
| Omeprazole | Omeprazole | 197 | 55 |
| Eliquis | Apixaban | 191 | 37 |
| Azithromycin | Azithromycin | 175 | 130 |
| Allopurinol | Allopurinol | 174 | 43 |
| Cefuroxime | Cefuroxime Axetil | 168 | 105 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 164 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 163 | 37 |
| Prednisone | Prednisone | 155 | 45 |
| Metformin Hcl | Metformin Hcl | 151 | 36 |
| Methylprednisolone | Methylprednisolone | 149 | 99 |
| Potassium Chloride | Potassium Chloride | 142 | 32 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 138 | 18 |
| Tramadol Hcl | Tramadol Hcl | 135 | 44 |
| Montelukast Sodium | Montelukast Sodium | 134 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 133 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 28 |
| Carvedilol | Carvedilol | 130 | 34 |
| Synthroid | Levothyroxine Sodium | 130 | 23 |
| Doxycycline Hyclate | Doxycycline Hyclate | 125 | 79 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 125 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 123 | 74 |
| Ramipril | Ramipril | 115 | 25 |
| Atenolol | Atenolol | 111 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 24 |
| Clonidine Hcl | Clonidine Hcl | 96 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 94 | 23 |
| Metformin Hcl Er | Metformin Hcl | 89 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 87 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 87 | 50 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 84 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 83 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 77 | 20 |
| Irbesartan | Irbesartan | 77 | 14 |
| Jardiance | Empagliflozin | 75 | 15 |
| Clonazepam | Clonazepam | 74 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 71 | 11 |
| Risperidone | Risperidone | 71 | suppressed |
| Ezetimibe | Ezetimibe | 69 | 13 |
| Cephalexin | Cephalexin | 68 | 42 |
| Mirtazapine | Mirtazapine | 68 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 66 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 65 | suppressed |
| Lorazepam | Lorazepam | 62 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 61 | 27 |
| Alendronate Sodium | Alendronate Sodium | 60 | 14 |
| Celecoxib | Celecoxib | 60 | 12 |
| Sertraline Hcl | Sertraline Hcl | 60 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 57 | suppressed |
| Ketoconazole | Ketoconazole | 57 | 31 |
| Myrbetriq | Mirabegron | 55 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 55 | 27 |
| Warfarin Sodium | Warfarin Sodium | 55 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 54 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 24 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 53 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 51 | 27 |
| Donepezil Hcl | Donepezil Hcl | 47 | 13 |
| Ibuprofen | Ibuprofen | 47 | 14 |
| Trazodone Hcl | Trazodone Hcl | 46 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 45 | 44 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 43 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | suppressed |
| Temazepam | Temazepam | 41 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 40 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 40 | suppressed |
| Diazepam | Diazepam | 39 | suppressed |
| Metolazone | Metolazone | 39 | 11 |
| Mupirocin | Mupirocin | 39 | 32 |
| Enalapril Maleate | Enalapril Maleate | 38 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 36 | 27 |
| Ozempic | Semaglutide | 36 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 35 | 18 |
| Memantine Hcl | Memantine Hcl | 35 | suppressed |
| Amoxicillin | Amoxicillin | 33 | 16 |
| Digoxin | Digoxin | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Finasteride | Finasteride | 33 | suppressed |
| Metaxalone | Metaxalone | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Clarithromycin | Clarithromycin | 31 | 25 |
| Clindamycin Hcl | Clindamycin Hcl | 31 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 16 |
| Gemfibrozil | Gemfibrozil | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Fluconazole | Fluconazole | 29 | 14 |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Mounjaro | Tirzepatide | 29 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 28 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 28 | 11 |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 16 |
| Scopolamine | Scopolamine | 27 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Tobramycin | Tobramycin | 24 | 19 |
| Captopril | Captopril | 23 | suppressed |
| Cilostazol | Cilostazol | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 22 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 22 | 18 |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | 17 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 21 | suppressed |
| Desoximetasone | Desoximetasone | 20 | 13 |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 13 |
| Solifenacin Succinate | Solifenacin Succinate | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 14 |
| Nystatin | Nystatin | 17 | suppressed |
| Spironolactone | Spironolactone | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 16 | 13 |
| Torsemide | Torsemide | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Vascepa | Icosapent Ethyl | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Tacrolimus | Tacrolimus | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Propylthiouracil | Propylthiouracil | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Travatan Z | Travoprost | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $987.33 · 8 records | Medtronic, Inc. | AIRSUPRA, CATALYFT PL EXPANDABLE INTERBODY SYSTEM, General - Pain Management, OPSUMIT, SYMPLICITY G3, Sunosi, UPTRAVI, VOQUEZNA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error